Tong Ren Tang
Tongrentang is a long-established brand of Chinese medicine industry
Tong Ren Tang, founded in June, 1997 and headquartered in Beijing, is a Chinese medicine company with long history. Listed on the SSE on June 25, 1997, the company's major shareholders are China Beijing Tongrentang (Group) Co., Ltd. and Anbang Life Insurance Inc.. Rivals that have direct and indirect competition with Tong Ren Tang include Harbin Pharmaceutical, Yunnan Baiyao, Glaxo Smith Kline, Pfizer, etc.
Ding Dang Kuai Yao: A Chinese E-Commercial Way to Run a Pharmacy
Are offline pharmacies still your preferred way to buy medicine? Many Chinese can get urgent drugs delivered to their door via WeChat. Ding Dang Kuai Yao’s CNY 1 billion Series B further is further proving the efficacy of this business.
Nov 02, 2020 10:33 AM
Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020
In the times of crisis like COVID-19, even established companies risk falling due to the sudden drop in their income. By contrast, companies that cling to innovation may unlock more value as they fight against the challenges.
Oct 20, 2020 07:40 PM
SoYoung, First Internet Medical Cosmetology Stock on Nasdaq: Not Easy to Move Forward
The hundreds of billions-level market potential of the Chinese medical cosmetology economy has attracted Meituan Dianping, Ali Health and JD Health to take a share. SoYoung, a beauty tips provider, is facing a more challenging situation than mere slumped business amid the COVID-19 quarantine.
Sep 15, 2020 12:26 PM
Ali Health Aims Higher with Rebranding and New Strategies
This month, Ali Health renamed its healthcare app 'Yi Lu' and adopted a cartoon image – a deer doctor. A Chinese play on words yields a secondary meaning along the lines of ‘well-being along the way.' More than this, though, the profile change is a signpost for a significant strategy upgrade.
Sep 11, 2020 10:43 AM
After China's BNR and GTH Hit Nasdaq, Pan-Cancer Detector GRAIL Eyes IPO
The early-stage cancer-detection technology has declared its mission: to take on and defeat the fatal illness, for the benefit of humanity. Following Burning Rock and Genetron Health, the US biotech GRAIL looks to go public on Nasdaq.
Sep 10, 2020 11:48 AM
Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role.
Sep 09, 2020 03:08 PM
More Room for the Medical Device Market to Grow in China
The medical device market in China is substantial – it also has massive niche markets. The domestic market size growth has surpassed that of the global market for many years, showing strong potential for development.
Aug 29, 2020 08:24 AM
Backed up by Rich Dad – What’s Next for Ping An Good Doctor?
Having a rich dad can help with capital and connections when a company is at the ‘infant’ stage. But being independent comes sooner or later. When shall that be for Ping An Good Doctor? Or will it not come at all?
Aug 27, 2020 01:02 PM
Modern Chinese Medicine Maker Tasly Pharmaceutical: An Old Stock in a New Package?
Tasly Pharmaceutical, founded in 1994 and listed on SSE in 2002, is valued at CNY 26.9 billion – a market cap that the company once achieved ten years ago. But did the company merely spin in circles during the last decade?
Jul 12, 2020 12:00 PM